Literature DB >> 20921424

DORADO: opportunity postponed: lessons from studies of endothelin receptor antagonists in treatment-resistant hypertension.

David J Webb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20921424     DOI： 10.1161/HYPERTENSIONAHA.110.160952

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  10 in total

Review 1.  Key advances in antihypertensive treatment.

Authors:  Ludovit Paulis; Ulrike M Steckelings; Thomas Unger
Journal:  Nat Rev Cardiol       Date:  2012-03-20       Impact factor: 32.419

Review 2.  Endothelin and the Cardiovascular System: The Long Journey and Where We Are Going.

Authors:  Andreas Haryono; Risa Ramadhiani; Gusty Rizky Teguh Ryanto; Noriaki Emoto
Journal:  Biology (Basel)       Date:  2022-05-16

3.  Anti-VEGF-Induced Hypertension: a Review of Pathophysiology and Treatment Options.

Authors:  Bryan J Brinda; Federico Viganego; Teresa Vo; Dawn Dolan; Michael G Fradley
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-05

Review 4.  Update on Endothelin Receptor Antagonists in Hypertension.

Authors:  Michel Burnier
Journal:  Curr Hypertens Rep       Date:  2018-05-19       Impact factor: 5.369

5.  Management of antiangiogenic therapy-induced hypertension.

Authors:  Nilka de Jesus-Gonzalez; Emily Robinson; Javid Moslehi; Benjamin D Humphreys
Journal:  Hypertension       Date:  2012-07-30       Impact factor: 10.190

Review 6.  Endothelins in cardiovascular biology and therapeutics.

Authors:  Neeraj Dhaun; David J Webb
Journal:  Nat Rev Cardiol       Date:  2019-08       Impact factor: 32.419

Review 7.  Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches.

Authors:  Thomas Unger; Ludovit Paulis; Domenic A Sica
Journal:  Eur Heart J       Date:  2011-09-27       Impact factor: 29.983

8.  Endothelin receptor antagonists for the treatment of diabetic nephropathy: A meta-analysis and systematic review.

Authors:  Li Zhang; Shuai Xue; Jie Hou; Guang Chen; Zhong-Gao Xu
Journal:  World J Diabetes       Date:  2020-11-15

Review 9.  Endothelin.

Authors:  Anthony P Davenport; Kelly A Hyndman; Neeraj Dhaun; Christopher Southan; Donald E Kohan; Jennifer S Pollock; David M Pollock; David J Webb; Janet J Maguire
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

Review 10.  Endothelin antagonism and its role in the treatment of hypertension.

Authors:  Rebecca C Moorhouse; David J Webb; David C Kluth; Neeraj Dhaun
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.